Simultaneous administration of multiple model substrates to assess hepatic drug clearance.
We have evaluated a method to simultaneously assess three major processes involved in hepatic drug clearance using three model substrates administered simultaneously as a 5-minute intravenous injection. Lorazepam, indocyanine green, and antipyrine are used to assess conjugation, liver blood flow, and microsomal oxidative metabolism, respectively. These substrates were administered individually and as a mixture to 10 healthy adult male volunteers to determine if clearances of any of the compounds were affected by simultaneous administration. Mean clearances of the substrates were not different when administered alone (9.97, 0.78, and 0.53 ml/min/kg) vs. together (11.5, 0.89, and 0.52 ml/min/kg), using a paired t test. Since we were using this method to assess hepatic drug clearance in children with leukemia, the effect of short-term allopurinol was assessed. The three model substrates were administered to the volunteers after 0, 1, 8, and 22 days of treatment with allopurinol, 200 mg t.i.d. There was no change in mean clearance of any of the three compounds at any point during allopurinol treatment (repeated-measures ANOVA). We conclude that this technique is a simple and valid method to simultaneously assess three major processes involved in hepatic drug clearance and is not affected by up to 22 days of oral allopurinol treatment. This simple technique, requiring a single set of blood samples, has potential applications in the assessment of developmental changes in hepatic drug clearance, as well as the effects of environmental, therapeutic, and pathophysiologic factors on three major processes involved in hepatic drug clearance.
D000284:Administration, Oral; D000328:Adult; D000493:Allopurinol / Q000494:pharmacology; D000983:Antipyrine / Q000008:administration & dosage / Q000378:metabolism*; D004347:Drug Interactions; D006801:Humans; D007208:Indocyanine Green / Q000008:administration & dosage / Q000378:metabolism*; D007262:Infusions, Intravenous; D008099:Liver / Q000378:metabolism*; D008140:Lorazepam / Q000008:administration & dosage / Q000378:metabolism*; D008297:Male; D008657:Metabolic Clearance Rate / Q000187:drug effects
D000493:Allopurinol; D007208:Indocyanine Green; D008140:Lorazepam; D000983:Antipyrine